← Leaderboards
Mary Kate Hart
Dynport Vaccine Company, Llc
$1,213,178
Attributed
$1,213,178
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $843.5K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$1,213,178 · 1
By mechanism
N01$1,213,178 · 1
Top collaborators
No co-investigators on record.
Most similar at Dynport Vaccine Company, Llc
Same institution · by research overlap
- Abraham Kallarkal$10,500
- Ian Henderson$11,140,403
- John T. Ross$5,388,306
- Salama Balume$16,877,312
- David Shumway$6,214,596
Others in their field
Other Rising Stars on “Biological Products”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Christina Millin · Rho Federal Systems Division, Inc.$23,515,000
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Kevin V Grimes · Stanford University$14,783,804
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
Research focus
Biological ProductsBiotechnologyService ProgramsServicesTherapeutic DevelopmentFungusMonoclonal AntibodiesPreclinical DevelopmentProduct DevelopmentEvaluationMucormycosisZygomycosis